Equaline Blue Ice Pain Relieving

Description

It appears that there are no extracted facts provided for the description section. Please provide the relevant details or bullet points about the drug, and I will assist you in creating a concise "Description" section.

Uses and Indications

This drug is indicated for the relief of pain in adults and children aged 2 years and older. It should be applied liberally to the affected area and massaged into the skin until fully absorbed. The application may be repeated no more than 3 to 4 times daily.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

No specific dosage or administration information is available. Healthcare professionals are advised to refer to the relevant prescribing information or clinical guidelines for detailed instructions regarding dosage and administration for the specific medication in question.

Contraindications

Use of this product is contraindicated in the following situations:

• Discontinue use and consult a physician if the condition worsens, symptoms persist for more than 7 days, or if symptoms clear up and recur within a few days.

• Patients with sensitive skin should consult a physician prior to use.

• If skin irritation develops, discontinue use and seek medical advice before further application.

• The product should not be used in conjunction with heating pads or heating devices.

• Avoid use, pouring, spilling, or storing the product near an open flame.

• Do not apply this product with other creams, sprays, or liniments.

• Application to damaged skin or wounds is contraindicated.

• Do not bandage the area tightly after application.

Warnings and Precautions

For external use only; contact with eyes and mucous membranes should be avoided to prevent irritation or adverse effects.

General precautions must be observed, including keeping the product out of reach of children. In the event of accidental ingestion, it is imperative to seek medical assistance or contact a Poison Control Center immediately.

Patients should discontinue use and consult a physician if their condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days. Additionally, individuals with sensitive skin are advised to consult a physician prior to use. Should skin irritation occur, the product should be discontinued, and medical advice should be sought before any further application.

Side Effects

Patients should be aware that this product is for external use only and must be kept away from the eyes and mucous membranes to prevent irritation.

In clinical use, if a patient's condition worsens, or if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days, it is advised to discontinue use of the product and consult a physician. Additionally, individuals with sensitive skin are encouraged to seek medical advice prior to using this product. Should skin irritation develop during use, it is important to discontinue application and consult a physician for further guidance.

Drug Interactions

There are no reported drug interactions associated with the use of this medication. Additionally, no interactions with laboratory tests have been identified. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Equaline Blue Ice Pain Relieving (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should not use this product unless specifically advised by a physician. For children aged 2 years and older, the product may be applied liberally to the painful area, with gentle massage until the gel is fully absorbed into the skin. Applications may be repeated no more than 3 to 4 times daily.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information regarding the use of EQUALINE BLUE ICE PAIN RELIEVING menthol gel during pregnancy. The drug insert does not provide safety concerns, dosage modifications, or special precautions for pregnant patients. Therefore, healthcare professionals should exercise caution when recommending this product to women of childbearing potential and consider the lack of data on potential fetal impacts. It is advisable to weigh the benefits against any unknown risks when considering the use of this product in pregnant patients.

Lactation

There is no specific information regarding nursing mothers or lactation considerations provided in the drug insert for EQUALINE BLUE ICE PAIN RELIEVING menthol gel. Therefore, healthcare professionals should exercise caution when recommending this product to lactating mothers. The potential effects on breastfed infants have not been established, and the excretion of the drug in human milk is unknown. It is advisable for lactating mothers to consult with their healthcare provider before using this product.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to consult local poison control centers or relevant toxicology resources for guidance on specific management protocols and antidotes, if applicable.

Documentation of the incident, including the substance involved, estimated dose, and time of exposure, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children. In the event of accidental ingestion, patients should seek medical help or contact a Poison Control Center immediately.

Patients should be informed that if their condition worsens, or if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days, they should discontinue use of the product and consult a physician.

For individuals with sensitive skin, it is recommended to consult a physician prior to use. If skin irritation develops, patients should discontinue use and seek the advice of a physician before continuing with the product.

Healthcare providers should instruct patients on specific precautions while using this product. Patients should not use it in conjunction with heating pads or heating devices, nor should they use, pour, spill, or store the product near an open flame. Additionally, patients should avoid using the product with other creams, sprays, or liniments, and it should not be applied to damaged skin or wounds. Bandaging the area tightly is also discouraged, as these actions may lead to excessive skin irritation or burns.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light exposure, to ensure optimal stability. Freezing the product is not recommended, as it may compromise its quality. After opening, the product should be discarded to prevent any potential degradation or contamination.

Additional Clinical Information

The product is administered topically, with instructions for adults and children over 2 years to apply liberally to the affected area and massage until absorbed. This application may be repeated no more than 3-4 times daily.

Clinicians should counsel patients that the product is for external use only and to avoid contact with eyes and mucous membranes. Patients are advised to discontinue use and consult a physician if the condition worsens, symptoms persist for more than 7 days, or if symptoms recur after clearing. Those with sensitive skin should seek medical advice before use, and if skin irritation occurs, they should discontinue use and consult a physician. Additionally, the product should be kept out of reach of children, and in the event of accidental ingestion, medical help or contact with a Poison Control Center is recommended.

Drug Information (PDF)

This file contains official product information for Equaline Blue Ice Pain Relieving, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)